Genentech, Inc. Spent $591,000 Lobbying The Federal Government On Biotech Issues In First Quarter

AP -- Genentech Inc. spent $591,000 in the first quarter lobbying the federal government on issues that could influence the market for its biotech drugs.

MORE ON THIS TOPIC